The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I imaging and pharmacodynamic trial of CS-1008 in patients (pts) with metastatic colorectal cancer (mCRC).
Marika Ciprotti
No relevant relationships to disclose
Niall C. Tebbutt
No relevant relationships to disclose
Fook Thean Lee
No relevant relationships to disclose
Sze Ting Lee
No relevant relationships to disclose
Dave C. McKee
No relevant relationships to disclose
Graeme J. O'Keefe
No relevant relationships to disclose
Sylvia J. Gong
No relevant relationships to disclose
Geoffrey Chong
No relevant relationships to disclose
Hui Kong Gan
No relevant relationships to disclose
Wendie Hopkins
No relevant relationships to disclose
Bridget Chappell
No relevant relationships to disclose
Fiona Elizabeth Scott
No relevant relationships to disclose
Martin W. Brechbiel
No relevant relationships to disclose
Archie N. Tse
Employment or Leadership Position - Daiichi Sankyo
Stock Ownership - Daiichi Sankyo
Mendel Jansen
Employment or Leadership Position - Daiichi Sankyo
Manabu Matsumura
Employment or Leadership Position - Daiichi Sankyo
Stock Ownership - Daiichi Sankyo
Rira Watanabe
Employment or Leadership Position - Daiichi Sankyo
Robert A. Beckman
Employment or Leadership Position - Daiichi Sankyo
Stock Ownership - Daiichi Sankyo; Johnson & Johnson
Jonathan Greenberg
Employment or Leadership Position - Daiichi Sankyo
Stock Ownership - Daiichi Sankyo
Andrew Mark Scott
No relevant relationships to disclose